Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Significance of Detection and Quantification of Circulating Tumor DNA in the Treatment of Melanoma Patients

NCT07422805 is registered in ClinicalTrials.gov with Institute of Oncology Ljubljana as lead sponsor.

NCT NCT07422805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07422805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Significance of Detection and Quantification of Circulating Tumor DNA in the Treatment of Melanoma Patients
Lead sponsor
Institute of Oncology Ljubljana
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
November 1, 2021
Completion date
November 30, 2026
Enrollment
176 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma, skin cancer